Covidien Files Form 10 Registration Statement in Connection with Spin-Off of Pharmaceuticals Business
plc (NYSE: COV) today announced the initial filing by Mallinckrodt plc
of a Form 10 Registration Statement with the U.S. Securities and
Exchange Commission (SEC) in connection with Covidien's previously
announced plan to spin off its Pharmaceuticals business.
"The filing of the Form 10 Registration Statement is an important
milestone in our ongoing separation process," said José E. Almeida,
Chairman, President and CEO. "As two distinct businesses, Covidien and
Mallinckrodt will be better positioned to capitalize on significant
growth opportunities and provide greater focus on their respective
businesses and strategic priorities. We remain on track to complete the
spin-off by mid-2013."